InflaRx IFRX 深 滬
已收盤 09-20 16:00:00 美东时间
1.55
+0.030
+1.97%
華盛通- 最 高1.60
- 今 開1.50
- 成交量 4.15万股
- 最 低 1.48
- 昨 收 1.52
- 總市值 9126.91万
- 52周最高 3.12
- 市盈率 靜 --
- 換手率 0.07%
- 52周最低 1.14
- 委 比 94.63%
- 總股本 5888.33万
- 歷史最高 53.10
- 量 比 0.73
- 振 幅 7.89%
- 歷史最低 0.776
- 每 手 1
- 風險率 0.38%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多InflaRx Announces $75M Share Sales Agreement
InflaRx (IFRX) has released an update. InflaRx N.V. has entered into a sales ag...
06-29 05:19
InflaRx’s Drug Enters BARDA Phase 2 ARDS Trial
InflaRx (IFRX) has released an update. InflaRx’s novel therapeutic candidate, G...
06-25 04:55
InflaRx’s INF904: A ‘Pipeline in a Drug’ with Multi-Market Potential Spurs Buy Rating
Analyst Edward White from H.C. Wainwright maintained a Buy rating on InflaRx (I...
06-06 18:18
InflaRx Unveils INF904’s Market Potential
InflaRx (IFRX) has released an update. InflaRx has showcased the potential of i...
06-06 06:00
HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $8 Price Target
HC Wainwright & Co. analyst Edward White reiterates InflaRx (NASDAQ:IFRX) with a Buy and maintains $8 price target.
05-09 18:52
InflaRx N.V. Reports Q1 2024 Financial Loss
Inflarx N.V. (IFRX) has released an update. InflaRx N.V., a biopharmaceutical c...
05-08 21:58
InflaRx GAAP EPS of -€0.17 beats by €0.07, revenue of €36.03M beats by €35.89M
InflaRx press release (NASDAQ:IFRX): Q1 GAAP EPS of -€0.17 beats by $0.07. Revenue of €36.03M beats by €35.89M. More on InflaRx Seeking Alpha’s Quant Rating on InflaRx Historical earnings data for Inf...
05-08 19:36
InflaRx N.V. Announces Share Capital Amendment
Inflarx N.V. (IFRX) has released an update. InflaRx N.V., a Dutch-based public ...
04-26 05:31
LifeSci Capital Reaffirms Their Hold Rating on InflaRx (IFRX)
In a report released today, Sam Slutsky from LifeSci Capital maintained a Hold ...
03-23 03:05
InflaRx Advances Anti-Inflammatory Therapeutics
Inflarx N.V. (IFRX) has released an update. InflaRx N.V., a biotech company spe...
03-22 09:27
